GIUSTINA, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 20.689
AS - Asia 8.588
EU - Europa 7.043
SA - Sud America 1.597
AF - Africa 132
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 21
Totale 38.092
Nazione #
US - Stati Uniti d'America 20.494
CN - Cina 3.181
SG - Singapore 2.802
UA - Ucraina 2.587
BR - Brasile 1.344
HK - Hong Kong 1.184
DE - Germania 1.042
PL - Polonia 772
FI - Finlandia 559
VN - Vietnam 433
GB - Regno Unito 423
FR - Francia 391
IE - Irlanda 368
TR - Turchia 367
RU - Federazione Russa 362
IT - Italia 311
IN - India 241
CA - Canada 110
BD - Bangladesh 95
AR - Argentina 85
ZA - Sudafrica 59
MX - Messico 55
SE - Svezia 54
IQ - Iraq 44
EC - Ecuador 43
ID - Indonesia 34
PY - Paraguay 34
ES - Italia 31
JP - Giappone 28
CZ - Repubblica Ceca 27
BE - Belgio 25
IR - Iran 25
SA - Arabia Saudita 25
MA - Marocco 23
CO - Colombia 22
NL - Olanda 21
CL - Cile 20
EU - Europa 20
PK - Pakistan 20
AU - Australia 19
VE - Venezuela 19
PE - Perù 18
UZ - Uzbekistan 18
AT - Austria 17
AE - Emirati Arabi Uniti 13
KE - Kenya 12
NP - Nepal 12
AZ - Azerbaigian 10
JO - Giordania 9
JM - Giamaica 8
IL - Israele 7
KZ - Kazakistan 7
LT - Lituania 7
PT - Portogallo 7
HN - Honduras 6
TN - Tunisia 6
UY - Uruguay 6
BO - Bolivia 5
DZ - Algeria 5
EG - Egitto 5
MU - Mauritius 5
RO - Romania 5
CI - Costa d'Avorio 4
EE - Estonia 4
ET - Etiopia 4
MY - Malesia 4
PA - Panama 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CH - Svizzera 3
GE - Georgia 3
KR - Corea 3
LV - Lettonia 3
NI - Nicaragua 3
OM - Oman 3
RS - Serbia 3
SN - Senegal 3
TW - Taiwan 3
AM - Armenia 2
BB - Barbados 2
CM - Camerun 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MN - Mongolia 2
SV - El Salvador 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BN - Brunei Darussalam 1
BW - Botswana 1
CR - Costa Rica 1
CY - Cipro 1
GD - Grenada 1
GR - Grecia 1
HR - Croazia 1
Totale 38.076
Città #
Fairfield 3.211
Woodbridge 2.446
Houston 1.750
Jacksonville 1.741
Ashburn 1.673
Singapore 1.358
Cambridge 1.303
Ann Arbor 1.282
Seattle 1.222
Hong Kong 1.175
Wilmington 1.112
Warsaw 769
Princeton 689
Nanjing 637
Beijing 622
Chandler 515
Dublin 367
New York 298
Istanbul 296
Nanchang 256
Los Angeles 231
Helsinki 203
Moscow 201
Des Moines 185
Shenyang 166
Buffalo 156
Ho Chi Minh City 154
Changsha 142
San Diego 131
Hebei 127
The Dalles 118
São Paulo 117
Tianjin 116
Jiaxing 112
Redondo Beach 104
Hanoi 98
Milan 94
Munich 80
Kunming 72
Shanghai 71
Jinan 68
Chicago 65
San Francisco 59
Brescia 55
Dallas 53
Dearborn 49
Hangzhou 49
Verona 47
Lancaster 44
Rio de Janeiro 40
Toronto 38
London 37
San Mateo 37
Lanzhou 36
Kocaeli 35
Santa Clara 34
Haikou 33
Johannesburg 32
Brooklyn 31
Guangzhou 31
Zhengzhou 31
Turku 30
Ningbo 29
Boardman 28
Dong Ket 28
Leawood 28
Tokyo 28
Belo Horizonte 27
Atlanta 26
Montreal 26
Brussels 24
Dhaka 24
Mexico City 24
Augusta 23
Phoenix 22
Poplar 22
Taizhou 22
Curitiba 21
Porto Alegre 21
Brasília 20
Brno 20
Stockholm 20
Denver 19
Manchester 19
Ardabil 18
Changchun 18
Boston 17
Quito 17
Ankara 16
Asunción 16
Biên Hòa 16
Charlotte 16
Taiyuan 16
Washington 16
Salvador 15
Tashkent 15
Orange 14
Ribeirão Preto 14
Cape Town 12
Chennai 12
Totale 27.103
Nome #
Elevated intraocular pressure in patients with acromegaly 325
High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome 293
Ghrelin regulates proliferation and differentiation of osteoblastic cells 246
Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients. 217
Guidelines for acromegaly management. 204
Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines 186
Effect of galanin on growth hormone (GH) response to thyrotropin releasing hormone of rat pituitary GH-secreting adenomatous cells (GH1) in culture. 172
Bone ultrasonometric features and grow hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy 172
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 172
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 171
Growth hormone deficiency in treated acromegaly 170
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy 169
A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin. 168
Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. 165
Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. 164
Role of stroma in haemoglobin synthesis: experiments on duck red cells in vitro. 164
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 158
Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation. 155
Comparative effect of porcine and rat galanin on growth hormone secretion in normal adult men. 154
Role of AMP-Activated Protein Kinase Activators in Antiproliferative Multi-Drug Pituitary Tumour Therapies: Effects of Combined Treatments with Compounds Affecting the mTOR-p70S6 Kinase Axis in Cultured Pituitary Tumour Cells 154
Growth, insulin-like growth factor I (IGF-I), and IGF-binding proteins 1 and 3 in children with severe liver disease before and after liver transplantation: a longitudinal and cross-sectional study 153
Long-term Picotamide, a dual thromboxane inhibitor, decreases urinary albumin excreation rate in type 2 diabetic patients with microalbuminuria at rest. 151
Development of Graves' hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto's hypothyroidism. 151
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. 146
Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment. 142
Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals 142
A consensus on criteria for cure of acromegaly. 141
The management of the patient with acromegaly and headache: a still open clinical challenge. 140
Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. 140
Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects. 140
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 139
Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. 138
Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects. 138
High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures 138
Diagnosis and treatment of acromegaly complications. 137
A single dose of aztreonam in the prevention of urinary tract infections in elderly catheterized patients. 137
Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis 136
Pituitary testing: a reappraisal. 136
Development of a meningioma in a patient with acromegaly during octreotide treatment: are there any causal relationships? 135
Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. 134
High prevalence of radiological vertebral fractures in HIV-infected males 134
Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly. 134
Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits. 134
The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. 133
Cardiovascular risk in aging and obesity: is there a role for GH. 133
AMP-activated protein kinase regulates normal rat somatotroph cell function and growth of rat pituitary adenomatous cell 132
ASSOCIATION BETWEEN L-THYROXINE TREATMENT, GH DEFICIENCY, AND RADIOLOGICAL VERTEBRAL FRACTURES IN PATIENTS WITH ADULT-ONSET HYPOPITUITARISM. 132
Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells 131
Effects of pasireotide (SOM230) on protein turnover and p70S6 kinase-S6 ribosomal protein signaling pathway in rat skeletal muscle cells 131
Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I. 130
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 130
Guidelines for acromegaly management: an update. 129
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review. 129
Long-term Picotamide, a dual thromboxane inhibitor, decreases both the urinary excretion of thromboxane B2 (TXB2) and albumin in patients with type 2 diabetes. 128
Growth hormone deficiency in the adult. 128
Role of galanin in the regulation of somatotrope and gonadotrope function in young ovulatory women. 127
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial 127
Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects. 126
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis. 126
A consensus on criteria for cure acromegaly 126
Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched italian multicenter study. 126
Impaired growth hormone (GH) response to pyridostigmine in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion. 126
Effects of short-term glucocorticoid deprivation on growth hormone (GH) response to GH-releasing hormone in man. 126
Development of isolated ACTH deficiency in a man with type I diabetes mellitus. 126
Expert consensus document:A consensus on the medical treatment of acromegaly 126
VERTEBRAL FRACTURES IN PATIENTS WITH ACROMEGALY: A 3 - YEAR PROSPECTIVE STUDY 126
New understanding and treatments for osteoporosis. 125
Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency 125
Prevalence of vertebral fractures in men with acromegaly 124
Growth hormone in glucocorticoid-induced osteoporosis. 124
Short-term effect of captopril and nifedipine on micro-albuminuria induced by exercise in hypertensive diabetic patients. 124
Octreotide for acromegaly treatment: a reappraisal. 124
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency. 123
Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. 123
Preliminary observations on the effects of acute infusion of growth hormone on coronary vasculature and on myocardial function and energetics of an isolated and blood-perfused heart. 123
Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man. 123
Glucocorticoids and the regulation of growth hormone secretion. 123
Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. 123
Acromegalic patients show the presence of hypertrophic remodelling of subcutaneous small resistance arteries 122
Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus. 122
[Effects of acute administration of nifedipine on exercise-induced microalbuminuria in normotensive patients with type 1 diabetes]. 122
TREATMENT OF HYPOTHYROIDISM:ALL THAT GLITTERS IS GOLD? 122
Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. 121
Effect of galanin on growth hormone (GH) response to thyrotropin releasing hormone of rat pituitary GH-secreting adenomatous cells (GH1) in culture. 121
Effects of the selective estrogen receptor modulator LY117018 on growth hormone secretion: in vitro studies. 120
Ambulatory blood pressure monitoring (ABPM) in normotensive patients with acromegaly effect of 24-h continous infusion of octreotide. 120
New oral anticoagulants and pituitary apoplexy 120
Influence of diabetes mellitus on vertebral fractures in men with acromegaly. 119
Acute effects of clonidine and growth-hormone-releasing hormone on growth hormone secretion in patients with hyperthyroidism. 119
TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS. 119
CORTISOL AND THE MUSCLE-BONE AXIS:RESPONSE TO COMMENTS BY MOLFINO ET AL. 119
Current guidelines for adult GH replacement. 118
Erectile dysfunction and coronary artery disease in patients with diabetes. 118
Transcutaneous oxygen tension as a potential predictor of cardiovascular events in type 2 diabetes: comparison with ankle-brachial index. 118
Somatostatin analogs selective for subtyps 2 and 5 of the somatostatin receptor suppress with different patterns growth hormone (GH) secretion in human GH-secreting adenoma cells cultured in vitro. 117
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 117
A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin. 117
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group. 117
Low-dose octreotide is able to cause a maximal inhibition of the glycemic responses to a mixed meal in obese type 2 diabetic patients treated with insulin. 117
BONE AND JOINT DISORDERS IN ACROMEGALY. 117
Totale 14.055
Categoria #
all - tutte 174.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.572 0 0 0 0 0 619 210 679 729 519 643 173
2021/20222.426 136 492 35 109 12 147 98 159 117 358 209 554
2022/20231.774 387 48 10 94 150 568 2 143 234 15 58 65
2023/20241.984 107 38 92 158 91 287 112 42 670 24 14 349
2024/20254.411 15 14 18 605 577 376 316 97 531 262 1.003 597
2025/20265.389 991 1.283 686 1.460 874 95 0 0 0 0 0 0
Totale 38.374